The Neurological Biomarkers Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Neurological Biomarkers Market?
The market size for neurological biomarkers has experienced significant expansion. It is projected to increase from $10.7 billion in 2024 to $11.96 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 11.7%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Neurological Biomarkers Industry?
The Neurological Biomarkers Global Market Report 2024 projects that by 2029, the market will reach $19.96 billion, growing at a compound annual growth rate (CAGR) of 13.7%.
Download Your Free Sample of the 2025 Neurological Biomarkers Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Neurological Biomarkers Market?
The key drivers in the neurological biomarkers market are:
• The surge in biomarkers for early disease detection
• Robust innovation in neuro-imaging technologies
• Strong advancements in omics technologies and AI integration
• Growing industry-research institution collaborations in diagnostic technologies
Global Market Segmentation: Identifying Major Neurological Biomarkers Industry Segments
The neurological biomarkers market covered in this report is segmented –
1) By Product: Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products
2) By Application: Alzheimer’s Disease, Parkinson’s Disease, Huntington's Disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy
3) By End-User: Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Other End-Users
Pre-order the 2025 Neurological Biomarkers Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Neurological Biomarkers Market?
The key trends in the neurological biomarkers market are:
• Technological innovation in imaging is a key emerging trend in the market.
• The sector is seeing rapid advancements in omics technologies.
• Integration of artificial intelligence (AI) is becoming increasingly common.
• Real-world evidence in biomarker validation, advancements in diagnostic technologies, and increased collaboration between industry and research institutions are shaping the future of the market.
Who Are the Top Competitors & Leading Players in the Neurological Biomarkers Market?
The major players in the neurological biomarkers market are:
• Pfizer Inc
Regional Dominance: Which Area Leads the Global Neurological Biomarkers Market?
North America was the largest region in the neurological biomarkers market in 2024
